Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,666   1.18  Index Moved Down -0.07%
MKS DEB ALY BAE Books Hybrid Mix Software Housewares 
United States  USA  |  Investing Themes


Processing
Collecting data for GSK and MRK ...

Asset Comparison and Correlation

 View All Portfolios 
    
Investment horizon: 
  30 Days    Login   to change
Run Correlation
 
 GlaxoSmithKline plc  vs   Merck & Co. Inc.
 Compare Fundamentals  
Daily Returns (%)
MRK   GSK   
 
Embed  Financial Widgets Catalog
Export  Financial Widgets Catalog
Timeline
Considering 30-days investment horizon, GlaxoSmithKline plc is expected to generate 0.68 times more return on investment than Merck. However, GlaxoSmithKline plc is 1.46 times less risky than Merck. It trades about 0.21 of its potential returns per unit of risk. Merck Co Inc is currently generating about -0.18 per unit of risk. If you would invest  5,112  in GlaxoSmithKline plc on April 20, 2013 and sell it today you would earn a total of  110.00  from holding GlaxoSmithKline plc or generate 2.15% return on investment over 30 days.

Diversification

Very weak diversification
Overlapping area represents amount of risk that can be diversified away by holding GlaxoSmithKline plc and Merck & Co. Inc. in the same portfolio assuming nothing else is changed

Correlation Coefficient

0.48
Parameters
Time Period1 Month [change]
DirectionPositive MRK Moved Up vs GSK
StrengthWeak
Accuracy100.0%
ValuesDaily Returns
Follow Correlation between GSK and MRK with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
Get Widget
 
Add Correlation between GSK and MRK to your reader
Syndicate
 
Share Correlation between GSK and MRK 
Find Opportunities
 
Predicted Return Density
 
Embed  Financial Widgets Catalog
Export  Financial Widgets Catalog
Returns   
MRK   GSK   

GlaxoSmithKline plc

Alpha
 
Profile
    
GlaxoSmithKl
Performance
10
Out Of
100
Over 30
Days
?
90% of all equities and portfolios perform better than GlaxoSmithKline plc. Compared with the overall equity markets, risk-adjusted returns on investments in GlaxoSmithKline plc are ranked lower than 10 (%) of all global equities and portfolios over the last 30 days.
Check Performance
Backtest
Predict Price
    

Match ups for GlaxoSmithKl

Johnson Johnson vs. GlaxoSmithKline plc
Pfizer Inc vs. GlaxoSmithKline plc
Novartis AG vs. GlaxoSmithKline plc
Sanofi vs. GlaxoSmithKline plc
Merck Co Inc vs. GlaxoSmithKline plc
BristolMyers Squibb Company vs. GlaxoSmithKline plc
AstraZeneca PLC vs. GlaxoSmithKline plc
Eli Lilly and Company vs. GlaxoSmithKline plc
Impax Laboratories Inc vs. GlaxoSmithKline plc
  

Merck Co Inc

Alpha
 
Profile
    
Merck
Performance
0
Out Of
100
Over 30
Days
?
Over the last 30 days Merck Co Inc has generated negative risk-adjusted returns adding no value to investors with long positions.
Check Performance
Backtest
Predict Price
    

Match ups for Merck

Johnson Johnson vs. Merck Co Inc
Pfizer Inc vs. Merck Co Inc
Novartis AG vs. Merck Co Inc
Sanofi vs. Merck Co Inc
GlaxoSmithKline plc vs. Merck Co Inc
BristolMyers Squibb Company vs. Merck Co Inc
AstraZeneca PLC vs. Merck Co Inc
Eli Lilly and Company vs. Merck Co Inc
Impax Laboratories Inc vs. Merck Co Inc


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
Take our survey
  
Financial Widget
Financial Widgets
Financial Content
Investing Content
Get Stock Ticker
Stock Tickers
 
Opportunities   Themes   Suggestions
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
  © 2013 Macroaxis Inc. All rights reserved       Custom Reporting   Advertising   Mobile Access   Retirement Grader   Alpha Search   Compare Stocks
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium